Dermatology

In some skin conditions, such as severe wounds and burns, topical medications containing hyaluronic acid (HA), a natural biopolymer that is also found in the human body, plays a key role in the skin’s cicatrisation process.

In the dermatology area IBSA has developed a portfolio of products that contain highly purified hyaluronic acid obtained through a certified, patented, bio-fermentation process:

• a cream formulation and a medicated gauze pad indicated for the treatment of non-infected wounds and burns, including ulcers of different origin and post-surgical wounds.
• the same pharmaceutical forms  are also available as a  synergic combination of HA and silver sulfadiazine, an effective antibacterial molecule. This topical combination leads to new therapeutic options for reducing the bacterial burden in the surface wound compartment.

The hyaluronic acid line is completed by a spray and a gel formulation indicated for cutaneous irritations of different origin (i.e. wind, sun, cold, sweat, shaving, aesthetic treatments and tattoos).

Among the numerous medical conditions that can affect the skin, psoriasis is a very common one, which may turn into a real disability for many people, affecting their daily life and leading to severe psychological problems (24% of patients with severe psoriasis experience depression). Moreover, the disease follows a frustrating pattern of remissions and relapses, with stress playing an important role.

There is no cure, but medicaments with corticosteroids such as Betamethasone Valerate (BMV) are an excellent symptomatic treatment. BMV has anti-inflammatory, antipruritic and vasoconstrictive properties which makes it effective in reducing the symptoms of psoriasis. This treatment is often carried out under occlusion to increase its efficacy.

The innovative BMV plaster, which has been recently developed and now available in different countries worldwide, combines the efficacy of BMV under occlusion to the controlled release of the active principle, as well as to an improved compliance of the treatment.